Literature DB >> 7488456

Favourable outcome in idiopathic ventricular fibrillation with treatment aimed at prevention of high sympathetic tone and suppression of inducible arrhythmias.

H J Crijns1, A C Wiesfeld, J L Posma, K I Lie.   

Abstract

OBJECTIVE: In the absence of an obvious cause for cardiac arrest, patients with idiopathic ventricular fibrillation are difficult to manage. A subset of patients has inducible arrhythmias. In others sympathetic excitation plays a role in the onset of the cardiac arrest. This study evaluates a prospective stepped care approach in the management of idiopathic ventricular fibrillation, with therapy first directed at induced arrhythmias and secondly at adrenergic trigger events.
SETTING: University Hospital. PATIENTS: 10 consecutive patients successfully resuscitated from idiopathic ventricular fibrillation.
INTERVENTIONS: Programmed electrical stimulation to determine inducibility, followed by serial drug treatment. Assessment of pre-arrest physical activity and mental stress status by interview, followed by beta blockade. Cardioverter-defibrillator implantation in non-inducible patients not showing significant arrest related sympathetic excitation. MAIN OUTCOME MEASURE: Recurrent cardiac arrest or ventricular tachycardia.
RESULTS: Five patients were managed with serial drug treatment and four with beta blockade. In one patient a defibrillator was implanted. During a median follow up of 2.8 years (range 6 to 112 months) no patient died or experienced defibrillator shocks. One patient had a recurrence of a well tolerated ventricular tachycardia on disopyramide.
CONCLUSIONS: Idiopathic ventricular fibrillation may be related to enhanced sympathetic activation. Prognosis may be favourable irrespective of the method of treatment. Whether the present approach enhances prognosis of idiopathic ventricular fibrillation remains to be determined. However, it may help to avoid potentially hazardous antiarrhythmic drugs or obviate the need for implantation of cardioverter-defibrillators.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7488456      PMCID: PMC484048          DOI: 10.1136/hrt.74.4.408

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  28 in total

1.  Ventricular fibrillation survivors in whom tachyarrhythmia cannot be induced: outcome related to selected therapy.

Authors:  J Kron; P J Kudenchuk; E S Murphy; C D Morris; K Griffith; C G Walance; J H McAnulty
Journal:  Pacing Clin Electrophysiol       Date:  1987-11       Impact factor: 1.976

2.  Out-of-hospital cardiac arrest. Use of electrophysiologic testing in the prediction of long-term outcome.

Authors:  D J Wilber; H Garan; D Finkelstein; E Kelly; J Newell; B McGovern; J N Ruskin
Journal:  N Engl J Med       Date:  1988-01-07       Impact factor: 91.245

3.  Importance of lead selection in QT interval measurement.

Authors:  J C Cowan; K Yusoff; M Moore; P A Amos; A E Gold; J P Bourke; S Tansuphaswadikul; R W Campbell
Journal:  Am J Cardiol       Date:  1988-01-01       Impact factor: 2.778

4.  Prognostic significance of arrhythmia inducibility or noninducibility at initial electrophysiologic study in survivors of cardiac arrest.

Authors:  R A Freedman; C D Swerdlow; V Soderholm-Difatte; J W Mason
Journal:  Am J Cardiol       Date:  1988-03-01       Impact factor: 2.778

5.  Ergonovine maleate provocative test for coronary arterial spasm.

Authors:  F A Heupler; W L Proudfit; M Razavi; E K Shirey; R Greenstreet; W C Sheldon
Journal:  Am J Cardiol       Date:  1978-04       Impact factor: 2.778

6.  The long-term prognosis of patients with out-of-hospital cardiac arrest but no inducible ventricular tachycardia.

Authors:  P T Sager; R Choudhary; C Leon; S H Rahimtoola; A K Bhandari
Journal:  Am Heart J       Date:  1990-12       Impact factor: 4.749

7.  Spatial variation of QT intervals in normal persons and patients with acute myocardial infarction.

Authors:  D M Mirvis
Journal:  J Am Coll Cardiol       Date:  1985-03       Impact factor: 24.094

8.  Determinants of survival in patients with ventricular tachyarrhythmias.

Authors:  C D Swerdlow; R A Winkle; J W Mason
Journal:  N Engl J Med       Date:  1983-06-16       Impact factor: 91.245

9.  Ventricular tachyarrhythmia associated with psychological stress. The role of the sympathetic nervous system.

Authors:  M A Brodsky; D A Sato; L T Iseri; L J Wolff; B J Allen
Journal:  JAMA       Date:  1987-04-17       Impact factor: 56.272

10.  Idiopathic ventricular fibrillation: inducibility and beneficial effects of class I antiarrhythmic agents.

Authors:  B Belhassen; I Shapira; D Shoshani; A Paredes; H Miller; S Laniado
Journal:  Circulation       Date:  1987-04       Impact factor: 29.690

View more
  3 in total

1.  Transvenous or subcutaneous implantable cardioverter defibrillator: a review to aid decision-making.

Authors:  Milena Leo; Alexander J Sharp; Andre Briosa E Gala; Michael T B Pope; Timothy R Betts
Journal:  J Interv Card Electrophysiol       Date:  2022-07-14       Impact factor: 1.759

2.  Recurrent cardiac events in patients with idiopathic ventricular fibrillation, excluding patients with the Brugada syndrome.

Authors:  Jean Champagne; Peter Geelen; François Philippon; Pedro Brugada
Journal:  BMC Med       Date:  2005-01-01       Impact factor: 8.775

Review 3.  Inherited arrhythmia syndrome predisposing to sudden cardiac death.

Authors:  Yun Gi Kim; Suk-Kyu Oh; Ha Young Choi; Jong-Il Choi
Journal:  Korean J Intern Med       Date:  2021-03-26       Impact factor: 2.884

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.